Table 4. Fluconazole susceptibility of 141 Candida clinical isolates.
| Species | Clinical specimens | Fluconazole susceptibility category (%) | ||
|---|---|---|---|---|
|
| ||||
| S | S-DD | R | ||
| C. albicans | Blood | 96.4 | 3.6 | - |
| Non-blood | 100 | - | - | |
| All | 98.4 | 1.6 | - | |
| C. parapsilosis [sensu lato] | Blood | 96 | 4.0 | - |
| Non-blood | 100 | - | - | |
| All | 97.5 | 2.5 | - | |
| C. tropicalis | Blood | 100 | - | - |
| Non-blood | 100 | - | - | |
| NC | 66.7 | 33.3 | - | |
| All | 95 | 5 | - | |
| C. guilliermondii | Blood | 100 | - | - |
| Non-blood | 100 | - | - | |
| All | 100 | - | - | |
| C. famata | Blood | 100 | - | - |
| Non-blood | 100 | - | - | |
| NC | - | - | - | |
| All | 100 | - | - | |
| C. glabrata | Blood | 100 | - | - |
| Non-blood | 100 | - | - | |
| All | 100 | - | - | |
| C. krusei | Blood | - | - | - |
| Non-blood | - | - | 100 | |
| All | - | - | 100 | |
| C. lambica | Blood | - | - | - |
| Non-blood | 100 | - | - | |
| All | 100 | - | - | |
| Overall | 97.2 | 2.1 | 0.7 | |
S, susceptible; S-DD, susceptible-dose dependent; R, resistant; NC, not-classified specimens.